
    
      The purpose of this study is to determine which of two delivery methods of PTH is preferred
      by patients after 14 days of use for each. Patient preference will be determined by means of
      patient questionnaires at the end of each treatment period and a final questionnaire after
      both treatment periods are complete. Adverse events will also be collected.
    
  